SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 37 filers reported holding SINOVAC BIOTECH LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $79,000 | 0.0% | 11,668 | -15.0% | 0.00% | – |
| Q4 2015 | $79,000 | +19.7% | 13,727 | +5.6% | 0.00% | – |
| Q3 2015 | $66,000 | -64.3% | 12,999 | -63.1% | 0.00% | – |
| Q2 2015 | $185,000 | -59.1% | 35,202 | -61.4% | 0.00% | – |
| Q1 2015 | $452,000 | -33.6% | 91,228 | -29.9% | 0.00% | – |
| Q4 2014 | $681,000 | -12.7% | 130,123 | -19.8% | 0.00% | – |
| Q3 2014 | $780,000 | -17.1% | 162,214 | -2.8% | 0.00% | – |
| Q2 2014 | $941,000 | +1033.7% | 166,803 | +1339.4% | 0.00% | – |
| Q1 2014 | $83,000 | -90.9% | 11,588 | -96.0% | 0.00% | – |
| Q4 2012 | $914,000 | +18.1% | 291,210 | -5.1% | 0.00% | – |
| Q3 2012 | $774,000 | +21.9% | 307,002 | +2.0% | 0.00% | – |
| Q2 2012 | $635,000 | +12.6% | 300,922 | +8.9% | 0.00% | – |
| Q1 2012 | $564,000 | – | 276,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Neumann Advisory Hong Kong Ltd | 402,844 | $3,005,000 | 1.62% |
| Sapphire Star Partners LP | 96,992 | $723,000 | 0.75% |
| Orbimed Advisors | 2,839,500 | $21,183,000 | 0.25% |
| Yorktown Management & Research Co Inc | 64,645 | $482,000 | 0.14% |
| NAVELLIER & ASSOCIATES INC | 31,865 | $238,000 | 0.03% |
| Renaissance Technologies | 5,172,930 | $41,625,000 | 0.02% |
| Freedom Investment Management, Inc. | 41,828 | $312,000 | 0.02% |
| Spark Investment Management LLC | 39,600 | $295,000 | 0.02% |
| Financial Gravity Asset Management, Inc. | 460 | $3,000 | 0.00% |
| SG Americas Securities, LLC | 24,021 | $179,000 | 0.00% |